Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03211793
PHASE1/PHASE2

Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis

Sponsor: UMC Utrecht

View on ClinicalTrials.gov

Summary

The MANUS Trial aims to examine the safety, feasibility and potential efficacy of intramuscularly injected allogeneic mesenchymal stromal cells as treatment for digital ulcers of systemic sclerosis.

Official title: Mesenchymal Stromal Cells for Angiogenesis and Neovascularisation in Digital Ulcers of Systemic Sclerosis: the MANUS Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2021-10-06

Completion Date

2026-11-01

Last Updated

2025-09-10

Healthy Volunteers

No

Interventions

DRUG

Mesenchymal stromal cells

8 intramuscular injections at designated sites in the hand/forearm muscles of the most affected side. Blinded syringes will be used. Injections will be administered by an experienced clinician (plastic surgeon or hand surgeon).

OTHER

Placebo

8 intramuscular injections at designated sites in the hand/forearm muscles of the most affected side. Blinded syringes will be used. Injections will be administered by an experienced clinician (plastic surgeon or hand surgeon).

Locations (1)

Universitair Medisch Centrum Utrecht

Utrecht, Netherlands